Should Big Pharma spend more on marketing than R&D?
Nine out of 10 large pharma companies spend more on marketing than they do on R&D. It's a statistic often cited as a sign of industry greed, but it may be the best way to foster real innovation.
What are consumers’ telemedicine and remote monitoring priorities?
A Deloitte survey of U.S. healthcare consumers revealed that priorities for telemedicine and remote monitoring tend to focus on caregiving more than self care.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
#BIO2015: Open-source biopharma R&D improves late-stage success
Collaboration, even with competitors, helps usher a drug into successful development, a new report from Deloitte released at this week's BIO convention says.
Deloitte rolls out new EHR approach
Deloitte’s Healthcare Practice today unveiled its latest offering in the EHR space with Evergreen, which it says can help reduce hospital IT costs by as much as 30 percent and improve analytics and reporting. It can do so by using what Deloitte calls a “global staffing model” and a standardized design that is easy to […]
Report: Narrowing focus to a few drugs boosts revenue
We know the pharma industry’s in the midst of a sea change, but here’s an interesting smidgen of info: The larger companies that just focus in on a few therapeutic areas tend to deliver higher returns, a new Deloitte report says here: “Company size matters,” the report says, because “the larger the company, by revenue or […]
The biotechs that top Deloitte’s Fast 500 Tech: Boston Heart Diagnostics, Novavax and more
Deloitte recently released its 2014 Technology Fast 500 Rankings, and biotech companies ranked third-quickest in growth following software and internet firms. The biotech industry, over all, grew 940 percent this year – the lowest it’s been, actually, in the past decade. Last year, for instance, the it grew 2,723 percent, in 2012 it was 3,734 – the […]
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Rock Health adds 8 more startups and 3 new partners, including Deloitte and Abbott
Digital health incubator Rock Health is investing in eight new startups and teaming up with three new corporate entities – Blue Shield of California, Deloitte and global healthcare firm Abbott. The new startups being incubated span the healthcare spectrum, from HIPAA compliance to life sciences and biotech. Among them: — Accountable, an online platform that seeks […]
Regenstrief brings 10M EHRs to Deloitte’s big data gathering
MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences. The Regenstrief Institute and its network of hospitals and providers across Indiana have teamed up with ConvergeHEALTH, an effort spearheaded by Deloitte that aims to offer comprehensive data sharing among key organizations. The informatics […]
Innovate, aggregate, diversify, manage: Why hospitals are continuing to turn to M&A
Number-wise, hospital mergers and acquisitions in the U.S. dipped last year after reaching decade-high levels in 2012. But analysts don’t think the appetite for growth via M&A is dying down just yet. Regulatory changes and pressure from public and private insurers are driving new healthcare business models that aren’t going away. Simon Gisby, the managing […]
Medtech industry: In this ACO world, take pricing cues from biopharma, posthaste
By now, you’ve heard the medical device industry landscape is shifting. The term “innovation” needs new life breathed into it in the life sciences, major companies are turning over their business models to take a larger bite of the care continuum, value takes precedence over volume in an ACO-ACA world, around which M&A is whirling. […]
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
One tricky thing about transparency in healthcare is the piecemeal process
In Deloitte’s weekly healthcare industry insights this week, Dr. Harry Greenspun, a senior adviser at Deloitte Center for Health Solutions, poses an important, lingering question about transparency: What are the implications of only having some transparency in healthcare? Companies like PokitDok, Change Healthcare and Castlight Health have been winning over investors with their solutions for […]
Map offers glimpse of enrollment through health insurance exchanges
With the problems associated with the portal for the Obamacare health insurance exchange HealthCare.gov , 106,000 people managed to enroll at last count. People are also signing up for plans through the state exchanges and state partnership exchanges around the country. Deloitte’s Center for Health Solutions has produced a useful, state-by-state breakdown aggregating those numbers […]
Which burgeoning medical device & pharma companies landed on Deloitte’s Fast 500 list?
More than a dozen medical device, pharmaceutical and diagnostics companies made it to the top 100 of this year’s Deloitte’s Fast 500 Ranking. Each year, Deloitte compiles the list that highlights 500 of the fastest-growing tech companies in the U.S., as determined by revenue growth as submitted by the company. That means that most of […]
Big data is here. How to separate signal from noise? Six trends shaping healthcare analytics
Big data may be about to overwhelm the healthcare system. A little healthcare business intelligence tip: Data by itself won’t drive value and outcomes. Smart healthcare analytics will. In Deloitte’s DBrief, “Big Data Revolution: Unlocking Healthcare Analytics,” healthcare industry experts talked about the opportunities and barriers for industries across the care continuum to harness data, […]
Keckley: If medical device excise tax repeal goes through, it won’t be a ‘one and done’
The shining moment for a potential medical device excise tax repeal could come on the heels of the Obamacare-debt ceiling bill. If the medical device tax is in fact repealed as part of the debt ceiling deal Congress pushes through (or doesn’t), Paul Keckley, the former Executive Director of the Deloitte Center for Health Solutions, […]